EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis via Activating FAK Signal
Haojie Li,Xuhong Fu,Junjie Zhao,Chen Li,Lingmeng Li,Peiyan Xia,Jianping Guo,Wenyi Wei,Rong Zeng,Jiarui Wu,Yihong Sun,Liyu Huang,Xuefei Wang
DOI: https://doi.org/10.1158/1541-7786.MCR-21-0441
2022-01-01
Molecular Cancer Research
Abstract:In comparison with intestinal-type gastric cancer, diffuse-type gastric cancer (DGC) is more likely to recur, metastasize, and exhibit worse clinical outcomes; however, the underlying mechanism of DGC recurrence remains elusive. By employing an LC/MS-MS proteomic approach, we identified that exocyst complex component 4 (EXOC4) was significantly upregulated in DGC with recurrence, compared to those with nonrecurrence. High expression of EXOC4 was correlated with tumor metastasis and poor prognosis in patients with DGC. Moreover, EXOC4 promoted cell migration and invasion as well as the tumor metastasis of DGC cells. Mechanistically, EXOC4 regulated the phosphorylation of focal adhesion kinase (FAK) at Y397 sites by stimulating the secretion of integrin a5/(31/EGF and enhancing the interaction of FAK and integrin or EGFR. The FAK inhibitor VS-4718 reversed the metastasis mediated by EXOC4 overex-pression and suppressed the tumor growth of patient-derived xenografts derived from DGC with high EXOC4 expression. The EXOC4-FAK axis could be a potential therapeutic target for patients with DGC with high expression of EXOC4. Implications: The EXOC4-FAK axis promoted DGC metastasis and could be a potential therapeutic target for patients with DGC.